Latest News

The FDA approved the first dual-agent eye drops for presbyopia, offering a groundbreaking solution for age-related near vision loss.

Processed plant-based foods like breads and cereal can reduce the risk of diabetes and heart failure when they replace ultra-processed meats or sugary beverages.

Research shows weight regain after discontinuation of GLP-1 or GLP-1/GIP agonists is a significant risk.

Discover groundbreaking FDA-approved treatments, including at-home depression therapy, new biosimilars, and culturally relevant pain relief options.

Atebimetinib shows promise in enhancing pancreatic cancer treatment, achieving a 64% survival rate and improving patient quality of life.

Shawn Riser Taylor, PharmD, CPP, CDCES, reflects on a research career shaped by a commitment to patient-driven inquiry and a passion for collaborative, learner-engaged projects.

CMS announces the selection of 15 high-cost drugs for Medicare price negotiations, aiming to reduce prescription costs for older adults and taxpayers.

Key updates include treatment thresholds, dietary recommendations, and management strategies.

Pharmacists play a vital role in identifying and managing primary immunodeficiency diseases, enhancing patient outcomes through immunoglobulin therapy and education.

Dextromethorphan offers unique mechanisms and potential benefits over traditional antidepressants.

FDA approves a new quadruplet therapy for newly diagnosed multiple myeloma, enhancing treatment options for patients ineligible for stem cell transplant.

Pharmacists play a vital role in supporting multiple sclerosis patients by addressing medication challenges, educating on treatments, and navigating insurance hurdles.

Experts say SMS-based engagement tools can help pharmacists improve medication adherence and reduce hospital readmissions by addressing common patient barriers such as forgetfulness and cost.

Updated guidelines on PA call for expanded screening, treatment, and monitoring, creating opportunities for pharmacists to screen all patients with hypertension.

Cardiotoxic signals released from the kidneys may drive cardiovascular risk in patients with chronic kidney disease, opening the door to earlier detection and targeted treatment.

Recent research reveals no link between menopause hormone therapy and dementia risk, urging further studies to clarify its effects on cognitive health.

Effective medication management requires active patient involvement and understanding.

The FDA expands Cerezyme's approval for treating non-CNS symptoms of type 3 Gaucher disease, marking a significant advancement in patient care.

The study found that anxiety and depression in those with Parkinson disease were significantly associated with fatigue severity.

FDA's draft guidance on MRD and CR as end points accelerates multiple myeloma therapy approvals, enhancing patient access and transforming oncology practices.

New research reveals how specific gut bacteria in infants may reduce the risk of allergies and asthma, offering potential preventive strategies.